ADENOSINE-DEAMINASE ACTIVITY AND FIBRONECTIN LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID IN SARCOIDOSIS AND TUBERCULOSIS

被引:0
作者
ALBERA, C [1 ]
MABRITTO, I [1 ]
GHIO, P [1 ]
SOLIDORO, P [1 ]
MARCHETTI, L [1 ]
POZZI, E [1 ]
机构
[1] UNIV TURIN, DIV RESP DIS, DEPT CLIN & BIOL SCI, I-10124 TURIN, ITALY
来源
SARCOIDOSIS | 1993年 / 10卷 / 01期
关键词
ADENOSINE DEAMINASE; FIBRONECTIN; TUBERCULOSIS; BRONCHOALVEOLAR LAVAGE; ALVEOLAR LYMPHOCYTES; ACTIVATION ANTIGENS;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We have studied Adenosine Deaminase (ADA) activity and Fibronectin (FN) levels in Bronchoalveolar Lavage Fluid (BALF) from 50 patients with Sarcoidosis (15 active, 35 non active and from 24 patients with Pulmonary Tuberculosis in order to evaluate relationships between both ADA and FN in BALF and alveolitis data. BALF ADA activity increases in active sarcoidosis as well as in tuberculosis, as a result of activation, differentiation and proliferation of blood-derived mononuclear alveolar cells. In sarcoidosis this hypothesis is supported by the significant positive correlation observed between ADA activity and both the number of alveolar CD4+ lymphocytes and the number of alveolar lymphocytes bearing activation antigens (CD25 and VLA-1). BALF FN levels increase, showing highest values in active sarcoidosis. ADA and FN elevation in BALF from active sarcoidosis patients could be suggested as additional markers of disease activity. Highest BALF ADA/Albumin ratio observed in pulmonary tuberculosis patients suggests an increased local production and differentiates pulmonary tuberculosis from active sarcoidosis. Increased FN/Albumin ratio observed in non active sarcoidosis appears to be related to a similar mechanism during the reparative process following granulomatous inflammation.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 50 条
  • [21] Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy
    Fröde, TS
    Medeiros, YS
    MEDIATORS OF INFLAMMATION, 2001, 10 (04) : 223 - 227
  • [22] QUANTIFICATION OF FIBRONECTIN IN BRONCHOALVEOLAR LAVAGE FLUID AND IN LUNG PARENCHYMA - DIFFERENCES BETWEEN SMOKERS AND NONSMOKERS
    MENENDEZ, R
    MARCO, V
    RUBIO, V
    SOLE, A
    RESPIRATION, 1995, 62 (06) : 312 - 316
  • [23] The Course of Serum Adenosine Deaminase Levels in Patients with Pulmonary Tuberculosis
    Kartaloglu, Zafer
    Okutan, Oguzhan
    Bozkanat, Erkan
    Ugan, Mustafa Harun
    Ilvan, Ahmet
    TURKISH THORACIC JOURNAL, 2005, 6 (02) : 127 - 131
  • [24] Fibronectin in bronchoalveolar lavage fluid in lung cancer:: Tumor or inflammatory marker?
    Cremades, MJ
    Menéndez, R
    Rubio, V
    Sanchis, J
    RESPIRATION, 1998, 65 (03) : 178 - 182
  • [25] The course of serum adenosine deaminase levels in patients with pulmonary tuberculosis
    Kartaloglu, Zafer
    Okutan, Oguzhan
    Bozkanat, Erkan
    Ugan, M. Harun
    Ilvan, Ahmet
    MEDICAL SCIENCE MONITOR, 2006, 12 (11): : CR476 - CR480
  • [26] Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis
    Perez, Rafael L.
    Kimani, Anthony P.
    King, Talmadge E., Jr.
    Aguayo, Samuel M.
    Roman, Jesse
    RESPIRATION, 2007, 74 (03) : 297 - 303
  • [27] Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?
    Drent, M
    Jacobs, JA
    de Vries, J
    Lamers, RJS
    Liem, IH
    Wouters, EFM
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (06) : 1338 - 1344
  • [28] Effect of exposure of rats to cigarette smoke on 5′ nucleotidase and adenosine deaminase in bronchoalveolar lavage
    Anand, U
    Anand, CV
    Agarwal, R
    Kanaka, R
    MEDICAL SCIENCE RESEARCH, 1999, 27 (03): : 189 - 190
  • [29] DISTRIBUTION OF BRONCHOALVEOLAR CELLS AND FIBRONECTIN LEVELS IN BRONCHOALVEOLAR LAVAGE FLUIDS FROM PATIENTS WITH LUNG DISORDERS
    NAKSTAD, B
    BOYE, NP
    LYBERG, T
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1990, 50 (06) : 587 - 593
  • [30] MUCOSAL ADENOSINE-DEAMINASE ACTIVITY AND GASTRIC-ULCER HEALING
    NAMIOT, Z
    MARCINKIEWICZ, M
    JAROSZEWICZ, W
    STASIEWICZ, J
    GORSKI, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 243 (03) : 301 - 303